Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.

@article{Beek2007InhibinBI,
  title={Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.},
  author={Robert D van Beek and Marij Smit and Marry M van den Heuvel-Eibrink and Frank H. de Jong and Friederike G A J Hakvoort-Cammel and Cor van den Bos and Henk van den Berg and Rob F. A. Weber and Rob Pieters and Sabine M P F de Muinck Keizer-Schrama},
  journal={Human reproduction},
  year={2007},
  volume={22 12},
  pages={3215-22}
}
BACKGROUND The aim of this study was to evaluate the long-term gonadal sequelae after treatment for childhood Hodgkin's lymphoma with combination chemotherapy, using up to date fertility parameters and andrological evaluation, including for the first time inhibin B. METHODS There were 56 male patients treated from 1974-1998 for childhood Hodgkin's lymphoma with combination chemotherapy ABVD or EBVD (adriamycin/epirubicin, bleomycin, vinblastine, dacarbazine) with or without MOPP… CONTINUE READING